glp 1 drugs and parkinson's disease A Big Week for GLP-1 - by Eric Topol GLP-1 Agonists: A New Frontier
Description
J Pharmacol Exp Ther 2006;317:11061113
The median time from initiation of semaglutide to the most recent HbA1c measurement was 928 days (IQR 2161,343
Available from: Wang Y, Song X, Zhuang L, Lang H, Yu L, Yan X, et al
A 72-week, double-blind phase 2 trial showed that once-daily administration of semaglutide had a significant therapeutic effect on NASH (193)
Tirzepatide may improve glycemic control by directly and indirectly affecting the pancreas and other tissues
Garrett Evensen, Edmund Pakhlevanyan, and April Williams of Salk
